Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review. - Wikidata - wikimedia - TriplyDB

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

http://www.wikidata.org/entity/Q34550556

about

Adult-onset acne: prevalence, impact, and management challenges.

P2860

Q49228254-CA55FD78-3200-4A5F-AEEB-5656DD4EC12A

P2860

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

http://www.wikidata.org/entity/Q34550556

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@ast

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@en

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@nl

type

label

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@ast

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@en

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@nl

prefLabel

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@ast

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@en

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@nl

P1433

Q34550556-618D5B93-5740-4B0F-93FD-8F4715A53DAE

P1476

Q34550556-AD5D62C0-0B77-4074-AFA8-08BC219F3343

P2093

Q34550556-03243F15-1500-4A2D-B72C-EE4C0FCB6204

Q34550556-784C515C-125D-4F85-90EB-2925BB44618C

Q34550556-FB3EBB15-8B56-4374-B784-FEB7FB082815

P275

Q34550556-34100920-97FC-4C56-9CB0-92DB02B3511B

P2860

Q34550556-00D45345-AF1D-4ABE-8064-665F145CDB96

Q34550556-04CE27C0-50C3-4520-8DAE-ED9146F029A0

Q34550556-13D27D54-0D2A-4640-B724-8BF7FA4F6A64

Q34550556-151DD7B7-476F-44C9-902B-9718816115EB

Q34550556-15472392-56C1-468F-A231-F38626C408A0

Q34550556-174226E6-F362-4D55-8F43-D905133EE43C

Q34550556-17BAC13E-5C8A-49B1-8C9A-9938653E903E

Q34550556-17C46887-B248-45B2-9E38-6829F6FC2ED3

Q34550556-1B9CA9E4-9DB3-4439-B61A-77265B1EDC8F

Q34550556-1F7EC4EA-F622-42D1-B61C-2A8BC6425569

P2888

Q34550556-628FFC15-573F-4276-A4F9-A5ECA692F057

P304

Q34550556-0E68A1B2-97EB-4034-89B3-47DA9E90C866

P31

Q34550556-21FFFFBF-9609-436E-BAF3-88E6266D1DB3

Q34550556-E27C99DB-1C5C-41EB-AE8B-758B30488AA9

Q34550556-e018e3f4-4dfd-a9d9-2379-08fb00966d42

P356

Q34550556-16933C60-9385-4CD7-A48E-BEA2382B4C39

P433

Q34550556-139DF428-60A3-4618-A022-AC0BCB31082D

P478

Q34550556-5C0AC3C7-D332-4005-87D4-8E85357259B7

P50

Q34550556-48619389-C794-4C3B-ACBB-4B01B9870227

Q34550556-89449A85-3436-4F70-8E3F-8929E3D4820C

Q34550556-E5E86D59-3872-4E28-BBC6-088835BB6EF2

P5008

Q34550556-F45F3E4F-7C3A-4D83-A3D4-FC5B0952B205

P577

Q34550556-20A83595-AA25-4EC7-B492-8F056D0E78D4

Q34550556-EFA2266E-8ABD-49B7-A4BC-E5BB85EFD54C

P6179

Q34550556-48D9F583-06C3-416A-94EC-CD56EB1CEEAF

P698

Q34550556-CA40FEB7-175F-4765-827F-038B10351034

P921

Q34550556-2DEEAB22-43EF-4184-953F-A6C812FA8A8C

Q34550556-A42D8870-3859-4392-B8B6-2A82C44B5D93

Q34550556-B75680B7-D7D3-4B36-BED7-781EE433E170

Q34550556-C250F480-89EE-46FF-92CE-E2DA3B35BD9E

Q34550556-D745E3F3-0ABE-49CD-A3FA-4F1DC8BFC8CA

P932

Q34550556-6735BD74-F597-40CF-BC03-4AA712D0AAF9

P356

S40257-016-0245-X

P1433

American Journal of Clinical Dermatology

P1476

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

@en

P2093

Alison M Layton

http://www.w3.org/2001/XMLSchema#string

Heather Whitehouse

http://www.w3.org/2001/XMLSchema#string

James Q Del Rosso

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Combined oral contraceptive pills for treatment of acne

Combined oral contraceptive pills for treatment of acne

Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne

Guidelines of care for the management of acne vulgaris

Classification and pharmacology of progestins

Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea

Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne

Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study.

Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.

The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.

P2888

s40257-016-0245-x

P304

169-191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1007/S40257-016-0245-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Zbys Fedorowicz

Esther J van Zuuren

P5008

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083524431

http://www.w3.org/2001/XMLSchema#string

P698

28155090

http://www.w3.org/2001/XMLSchema#string

P921

hyperandrogenism

antimineralocorticoid

P932

5360829

http://www.w3.org/2001/XMLSchema#string